5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
C90H78BrF9N16O7 — CID 158580540
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole (PubChem CID 158580540) has the molecular formula C90H78BrF9N16O7 and a molecular weight of 1746.60 g/mol. Its IUPAC name is 5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 158580540 |
| Molecular Formula | C90H78BrF9N16O7 |
| Molecular Weight | 1746.60 g/mol |
| Exact Mass | 1744.53 |
| IUPAC Name | 5-[3,5-bis(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;5-[3-bromo-5-(trifluoromethyl)phenyl]-3-phenyl-1,2,4-oxadiazole;tert-butyl 2-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenyl]piperidine-1-carboxylate;5-(3-piperidin-4-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(4-piperidin-2-ylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole |
| SMILES | CC(C)(C)OC(=O)N1CCCCC1c1ccc(-c2nc(-c3ccncc3)no2)cc1.FC(F)(F)c1cc(-c2nc(-c3ccccc3)no2)cc(C(F)(F)F)c1.FC(F)(F)c1cc(Br)cc(-c2nc(-c3ccccc3)no2)c1.c1cc(-c2nc(-c3ccncc3)no2)cc(C2CCNCC2)c1.c1cc(-c2noc(-c3ccc(C4CCCCN4)cc3)n2)ccn1 |
| InChI | InChI=1S/C23H26N4O3.2C18H18N4O.C16H8F6N2O.C15H8BrF3N2O/c1-23(2,3)29-22(28)27-15-5-4-6-19(27)16-7-9-18(10-8-16)21-25-20(26-30-21)17-11-13-24-14-12-17;1-2-15(13-4-8-19-9-5-13)12-16(3-1)18-21-17(22-23-18)14-6-10-20-11-7-14;1-2-10-20-16(3-1)13-4-6-15(7-5-13)18-21-17(22-23-18)14-8-11-19-12-9-14;17-15(18,19)11-6-10(7-12(8-11)16(20,21)22)14-23-13(24-25-14)9-4-2-1-3-5-9;16-12-7-10(6-11(8-12)15(17,18)19)14-20-13(21-22-14)9-4-2-1-3-5-9/h7-14,19H,4-6,15H2,1-3H3;1-3,6-7,10-13,19H,4-5,8-9H2;4-9,11-12,16,20H,1-3,10H2;1-8H;1-8H |
| InChIKey | HTEXCWXIQRVISY-UHFFFAOYSA-N |
| XLogP | 22.77 |
| TPSA | 286.87 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 123 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1746.60 |
| LogP ≤ 5 | 22.77 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158580540 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.